Mimedx (MDXG) Invested Capital (2010 - 2026)

Mimedx has disclosed Invested Capital across 17 years of filings, most recently posting $242.9 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $242.9 million, up 19.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $242.9 million (up 19.14% YoY), and the FY2025 annual result was $274.5 million, up 29.44% from the prior year.
• Invested Capital came in at $242.9 million for Q1 2026 at Mimedx, down from $274.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $274.5 million in Q4 2025 to a low of $29.0 million in Q3 2022.
• The 5-year median for Invested Capital is $170.2 million (2024), against an average of $137.9 million.
• Across the five-year window, Invested Capital sank 36.51% in 2022 and soared 529.67% in 2023, its largest moves.
• Mimedx's Invested Capital stood at $30.6 million in 2022, then jumped by 529.67% to $192.7 million in 2023, then rose by 10.06% to $212.1 million in 2024, then increased by 29.44% to $274.5 million in 2025, then fell by 11.51% to $242.9 million in 2026.
• The last three Invested Capital figures came in at $242.9 million (Q1 2026), $274.5 million (Q4 2025), and $238.9 million (Q3 2025), per Business Quant data.